.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Julphar
Chubb
Federal Trade Commission
Citi
Healthtrust
Dow
Fuji
Covington
Teva

Generated: July 24, 2017

DrugPatentWatch Database Preview

PERINDOPRIL ERBUMINE Drug Profile

« Back to Dashboard

What is the patent landscape for Perindopril Erbumine, and what generic Perindopril Erbumine alternatives are available?

Perindopril Erbumine is a drug marketed by Ani Pharms Inc, Apotex, Lupin Ltd, Aurobindo Pharma, and West-ward Pharms Int. and is included in five NDAs.

The generic ingredient in PERINDOPRIL ERBUMINE is perindopril erbumine. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the perindopril erbumine profile page.

Summary for Tradename: PERINDOPRIL ERBUMINE

Patents:0
Applicants:5
NDAs:5
Suppliers / Packagers: see list3
Bulk Api Vendors: see list33
Clinical Trials: see list41
Patent Applications: see list872
Drug Prices:see details
DailyMed Link:PERINDOPRIL ERBUMINE at DailyMed

Pharmacology for Tradename: PERINDOPRIL ERBUMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL078138-001Nov 10, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Ltd
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL078263-001Jan 27, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Apotex
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL090463-001Aug 30, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL079070-003Nov 10, 2009ABRXNoYes► Subscribe► Subscribe► Subscribe
Lupin Ltd
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL078263-002Jan 27, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Novartis
Chubb
Queensland Health
Chinese Patent Office
Cantor Fitzgerald
Julphar
Harvard Business School
Colorcon
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot